Avinza - 24-h sustained-release oral morphine therapy
Caldwell JR.
Radiant Research, Daytona Beach,
FL 32114, USA.
Expert Opin Pharmacother. 2004 Feb;5(2):469-72


Avinza is a once-daily, extended-release oral morphine preparation. It has a pharmacokinetic profile that exhibits less peak-to-trough fluctuations in plasma concentration whilst providing analgesia statistically identical to that produced by MS Contin (controlled-release morphine sulfate), Oxycontin (oxycodone HCl controlled-release) and six doses of oral morphine sulfate administered every 4 h. Avinza improves quality of sleep by several measures but interestingly gives the best sleep improvement when given in the morning rather than at night. It causes the same side effects of other opioids: constipation, nausea, vomiting, somnolence and mood swings. Doses of 30 - 60 mg/day have been shown to be well tolerated by patients with osteoarthritis (even in the elderly), who have failed other medications.
Morphine plus Viagra
Fentanyl and ketamine
Morphine and serotonin
Morphine and magnesium
Is morphine a smart drug?
Neurokinin-1/Substance P
Opioids, mood and cognition
Is morphine an antidepressant?
Methadone, morphine and heroin
Depressed laboratory rats and drug policy
Opioids, depression and learned helplessness
Morphine as a neurotransmitter/neuromodulator
Morphine (Avinza): prescribing information (PDF)
Morphine (Kadian): prescribing information (PDF)

and further reading

Future Opioids
BLTC Research
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family